Linear and head to tail cyclic hexapeptide analogs (Xaa-Thr-Thr-Asn-Ty
r-Thr, Xaa = D-Asp or D-iso-Asp) of peptide T were prepared and tested
for human monocyte chemotaxis. All new compounds showed significant b
ioactivity. In particular, the conformational restriction introduced i
nto cyclo(-D-iso-Asp-Thr-Thr-Asn-Tyr-Thr-) was very suitable for CD4 r
eceptor binding. The cyclic peptides also proved to be highly resistan
t to degradation by plasma or brain enzymes.